186 related articles for article (PubMed ID: 38600057)
1. Effect of 2-methoxyestradiol on mammary tumor initiation and progression.
Peta KT; Durandt C; van Heerden MB; Joubert AM; Pepper MS; Ambele MA
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2068. PubMed ID: 38600057
[TBL] [Abstract][Full Text] [Related]
2. Effect of 2-methoxyestradiol treatment on early- and late-stage breast cancer progression in a mouse model.
Peta KT; Durandt C; van Heerden MB; Joubert AM; Pepper MS; Ambele MA
Cell Biochem Funct; 2023 Oct; 41(7):898-911. PubMed ID: 37649158
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment.
García-Mendoza MG; Inman DR; Ponik SM; Jeffery JJ; Sheerar DS; Van Doorn RR; Keely PJ
Breast Cancer Res; 2016 May; 18(1):49. PubMed ID: 27169366
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma plasma levels and presence of mouse mammary tumor virus-like env gene: Implications on the pathogenesis of breast cancer.
de Sousa Pereira N; Motoori-Fernandes C; Banin-Hirata BK; Vitiello GAF; de Oliveira CEC; Amarante MK; Watanabe MAE
Cytokine; 2023 Sep; 169():156299. PubMed ID: 37451115
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of JAK1/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model.
Tang J; Liu C; Liu S; Zhou X; Lu J; Li M; Zhu L
Eur J Pharmacol; 2022 Oct; 933():175276. PubMed ID: 36130639
[TBL] [Abstract][Full Text] [Related]
6. 2-methoxyestradiol inhibits melanoma cell growth by activating adaptive immunity.
Hua W; Huang X; Li J; Feng W; Sun Y; Guo C
Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):541-547. PubMed ID: 35451929
[No Abstract] [Full Text] [Related]
7. Liposomal 2-Methoxyestradiol Nanoparticles for Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model.
Borahay MA; Vincent KL; Motamedi M; Tekedereli I; Salama SA; Ozpolat B; Kilic GS
Reprod Sci; 2021 Jan; 28(1):271-277. PubMed ID: 32632769
[TBL] [Abstract][Full Text] [Related]
8. COX-2 modulates mammary tumor progression in response to collagen density.
Esbona K; Inman D; Saha S; Jeffery J; Schedin P; Wilke L; Keely P
Breast Cancer Res; 2016 Mar; 18(1):35. PubMed ID: 27000374
[TBL] [Abstract][Full Text] [Related]
9. The effect of 2-methoxyestradiol liposome on growth inhibition, angiogenesis and expression of VEGF and Ki67 in mice bearing H22 hepatocellular carcinoma.
Du B; Wang SY; Shi XF; Zhang CF; Zhang ZZ
Tumori; 2011; 97(5):660-5. PubMed ID: 22158500
[TBL] [Abstract][Full Text] [Related]
10. The photodynamic reaction with IR-775 cyanine combined with 2-methoxyestradiol in ovarian (SKOV-3) and human breast adenocarcinoma (MDA MB-231) cell lines.
Waszkiewicz M; Choromanska A; Kulbacka J; Saczko J
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102766. PubMed ID: 35182779
[TBL] [Abstract][Full Text] [Related]
11. The anticancer effect of PQ1 in the MMTV-PyVT mouse model.
Shishido SN; Delahaye A; Beck A; Nguyen TA
Int J Cancer; 2014 Mar; 134(6):1474-83. PubMed ID: 24038078
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer.
Katara GK; Kulshrestha A; Schneiderman S; Riehl V; Ibrahim S; Beaman KD
Mol Oncol; 2020 Jan; 14(1):211-224. PubMed ID: 31725949
[TBL] [Abstract][Full Text] [Related]
13. Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms.
Zhao W; Wang H; Zhang X; Zhang L; Pu W; Ma Y; Chen W
BMC Pulm Med; 2024 Jan; 24(1):46. PubMed ID: 38254043
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.
Klauber N; Parangi S; Flynn E; Hamel E; D'Amato RJ
Cancer Res; 1997 Jan; 57(1):81-6. PubMed ID: 8988045
[TBL] [Abstract][Full Text] [Related]
15. Oral squamous cell carcinoma-derived EVs promote tumor progression by regulating inflammatory cytokines and the IL-17A-induced signaling pathway.
Li R; Zhou Y; Zhang M; Xie R; Duan N; Liu H; Qin Y; Ma J; Li Z; Ye P; Wang W; Wang X
Int Immunopharmacol; 2023 May; 118():110094. PubMed ID: 37030119
[TBL] [Abstract][Full Text] [Related]
16. IFI16/Ifi202 released from breast cancer induces secretion of inflammatory cytokines from macrophages and promotes tumor growth.
Lim GY; Cho SW; Ka NL; Lee KH; Im SA; Kim SS; Hwang S; Lee MO
J Cell Physiol; 2023 Jul; 238(7):1507-1519. PubMed ID: 37062941
[TBL] [Abstract][Full Text] [Related]
17. Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches.
Roy LD; Sahraei M; Schettini JL; Gruber HE; Besmer DM; Mukherjee P
BMC Cancer; 2014 Mar; 14():225. PubMed ID: 24674692
[TBL] [Abstract][Full Text] [Related]
18. Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression.
Huh JI; Calvo A; Charles R; Green JE
Cancer Res; 2006 Apr; 66(7):3495-503. PubMed ID: 16585173
[TBL] [Abstract][Full Text] [Related]
19. CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer.
Ball MS; Bhandari R; Torres GM; Martyanov V; ElTanbouly MA; Archambault K; Whitfield ML; Liby KT; Pioli PA
Sci Rep; 2020 Apr; 10(1):6560. PubMed ID: 32300202
[TBL] [Abstract][Full Text] [Related]
20. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation.
Kaplanov I; Carmi Y; Kornetsky R; Shemesh A; Shurin GV; Shurin MR; Dinarello CA; Voronov E; Apte RN
Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1361-1369. PubMed ID: 30545915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
